Skip to main content

Animations

MJFF Publications

2311 - 2320 of 8816 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • Summary Details
    OPEN
    Title: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.994114
    Citation Count: 4
  • Summary Details
    OPEN
    Title: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abm3233
    Citation Count: 214
  • Summary Details
    OPEN
    Title: ATP and NAD+ Deficiency in Parkinson’s Disease
    Journal Name: Nutrients
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/nu15040943
    Citation Count: 36
  • Summary Details
    OPEN
    Title: New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissues
    Journal Name: Frontiers in Molecular Biosciences
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fmolb.2023.1087982
    Citation Count: 9
  • Summary Details
    OPEN
    Title: A proteogenomic view of Parkinson’s disease causality and heterogeneity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00461-9
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/cells12030343
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Tissue specific LRRK2 interactomes reveal a distinct striatal functional unit
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1010847
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study
    Journal Name: American Journal of Speech-Language Pathology
    Publisher: American Speech Language Hearing Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1044/2022_ajslp-22-00063
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Data Archive for the BRAIN Initiative (DABI)
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-01972-z
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.